---
search:
  boost: 2 
---

# Androgens

This is a subcategory of Endocrine Agents.

## Decision Tree
[Androgens- Non-Preferred Agents (Age Restricted, PA) - Androderm, Testosterone Gel 1%, Testosterone Gel 1% Pump](https://forms.office.com.mcas.ms/pages/designpagev2.aspx?auth_pvr=OrgId&auth_upn=anttwaniqua.greer%40gainwelltechnologies.com&origin=OfficeDotCom&lang=en-US&sessionid=dba554c2-2c78-4f60-bee3-f837172c2546&route=GroupForms&subpage=design&id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUQTc1UVI3REpOOENJMkU4Uk9SNVJNWVYzMiQlQCN0PWcu&topview=Preview)

[Androgens- Non-Preferred Agents (Age Restricted) - Jatenzo, Methyltestosterone, Natesto, Testopel, Testosterone Cypionate, Testosterone Gel 1.62%, Testosterone Gel 2%, Testosterone Sol 30mg/ACT, Tlando, Xyosted](https://forms.office.com.mcas.ms/pages/designpagev2.aspx?auth_pvr=OrgId&auth_upn=anttwaniqua.greer%40gainwelltechnologies.com&origin=OfficeDotCom&lang=en-US&sessionid=dba554c2-2c78-4f60-bee3-f837172c2546&route=GroupForms&subpage=design&id=nPhjxpvvj0G9PUHkbAzgaN9UYz8EqmlIs3_TYn4TbXBUNjk0MkRCMVU1MkxZTFlZUjVCUURUWFdGTiQlQCN0PWcu&topview=Preview)

## Formulary

### Preferred

| Preferred                                 | Generic Name | Quantity | Time (Days) |
| :---------------------------------------- | :----------- | :------: | :---------: |
| Androderm <sup>AR PA</sup>                |              |          |             |
| Testosterone Gel 1% <sup>AR PA</sup>      |              |          |             |
| Testosterone Gel 1% Pump <sup>AR PA</sup> |              |          |             |

### Non-Preferred

| Non-Preferred                              | Generic Name | Quantity | Time (Days) |
| :----------------------------------------- | :----------- | :------: | :---------: |
| Jatenzo <sup>AR</sup>                      |              |          |             |
| Methyltestosterone <sup>AR</sup>           |              |          |             |
| Natesto <sup>AR</sup>                      |              |          |             |
| Testopel <sup>AR</sup>                     |              |          |             |
| Testosterone Cypionate <sup>AR</sup>       |              |          |             |
| Testosterone Gel 1.62% <sup>AR</sup>       |              |          |             |
| Testosterone Gel 2% <sup>AR</sup>          |              |          |             |
| Testosterone Sol 30 MG / ACT <sup>AR</sup> |              |          |             |
| Tlando <sup>AR</sup>                       |              |          |             |
| Xyosted <sup>AR</sup>                      |              |          |             |

## Authorizations

**Length of Authorizations**: 365 Days

**All Authorizations**: Must be prescribed in accordance with FDA approved labeling

## Criteria

### Clinical PA

Clinical PA Criteria

-   Must provide documentation of lab work to support the need for testosterone supplementation

### Non-Preferred

Non-Preferred Criteria

-   Must provide documentation of medical necessity beyond convenience for why the patient cannot be changed to a preferred dug (i.e., allergies, drug-drug interactions, contraindications, or intolerances) **OR**
    -   For any nonsolid oral dosage formulation: must provide documentation of medical necessity for why patient cannot be changed to a solid oral dosage
-   Must have had an inadequate clinical response of at least **90 days** with **all preferred** drugs
    -   For non-preferred extended-release formulations: must provide documentation of an inadequate clinical response with its immediate release formulation (if available)
    -   For non-preferred brand names that have preferred generics: must provide documentation of an inadequate clinical response or allergy to two or more generic labelers (if available)

### Subsequent Authorization

Subsequent Authorization Criteria

-   Must provide documentation of patientâ€™s clinical response to treatment and ongoing safety monitoring (i.e., testosterone and hematocrit)

**AR** - All drugs: a PA is required for patients younger than 18 years

## Links

[Criteria](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL%20_Criteria_APPROVED.pdf#page=51)

[Preferred Drug List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_UPDL_APPROVED_12.13.22.pdf#page=20)

[Quantity Limit List](https://pharmacy.medicaid.ohio.gov/sites/default/files/20230101_Ohio_Medicaid_Quantity_Document_APPROVED.pdf)
